Salmonella exploit host-derived nitrate for growth in the lumen of the inflamed intestine. The generation of host-derived nitrate is dependent on Nos2, which encodes inducible nitric oxide synthase (iNOS), an enzyme that catalyzes nitric oxide (NO) production. However, the cellular sources of iNOS and, therefore, NO-derived nitrate used by Salmonella for growth in the lumen of the inflamed intestine remain unidentified. Here, we show that iNOSproducing inflammatory monocytes infiltrate ceca of mice infected with Salmonella. In addition, we show that inactivation of type-three secretion system (T3SS)-1 and T3SS-2 renders Salmonella unable to induce CC-chemokine receptor-2-and CC-chemokine ligand-2-dependent inflammatory monocyte recruitment. Furthermore, we show that the severity of the pathology of Salmonella-induced colitis as well as the nitrate-dependent growth of Salmonella in the lumen of the inflamed intestine are reduced in mice that lack Ccr2 and, therefore, inflammatory monocytes in the tissues. Thus, inflammatory monocytes provide a niche for Salmonella expansion in the lumen of the inflamed intestine.
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Introduction
Salmonella enterica serovars are pathogenic bacteria that cause significant morbidity and mortality in humans worldwide [1] [2] [3] [4] . Non-typhoidal Salmonella (NTS) gastroenteritis is the most prevalent of the clinical syndromes associated with Salmonella enterica serovars. The global burden of NTS gastroenteritis is estimated to account for 93.8 million cases of disease annually, with 155,000 deaths [3] .
Salmonella enterica serovars such as Salmonella enterica serovar Typhimurium (STm) invade intestinal epithelial cells and induce a secretory response in the intestinal epithelium that initiates the recruitment of innate immune cells [5] . This inflammatory response is characterized by dense, suppurative-to-pyogranulomatous infiltration of the lamina propria and submucosa, and multifocal pyogranulomatous lymphadenitis [6] [7] [8] . While this inflammatory response helps limit STm invasion in the long term, numerous studies have shown that STm exploit gut inflammation to edge out competing microbes in the intestinal lumen and establish infection [9, 10] . Specifically, the inflammatory response changes the composition of the gut microbiota and suppresses its growth [11] [12] [13] . Furthermore, STm use by-products of the inflammatory response such as nitrate and tetrathionate as electron acceptors for anaerobic respiration and growth in the lumen of the inflamed intestine [14, 15] . The resulting increase in relative abundance of STm, a facultative anaerobe, is accompanied by changes in the gut microbiota that are characterized by a marked decrease in relative abundance of obligate anaerobes (e.g., Clostridia) [12, 13, 16] .
Host-derived nitrate is the preferred electron acceptor used by STm for anaerobic respiration and growth in the lumen of the inflamed intestine [17, 18] . The generation of host-derived nitrate is dependent on Nos2 [19] , which encodes inducible nitric oxide synthase (iNOS), an enzyme that catalyzes the production of nitric oxide (NO). However, the cellular source(s) of iNOS and, therefore, the NO-derived nitrate used by STm for growth in the lumen of the inflamed intestine remain unidentified.
Here, we show that iNOS-producing inflammatory monocytes (IM) infiltrate ceca of mice infected with STm and that inactivation of type-three secretion system (T3SS)-1 and T3SS-2 renders STm unable to induce CC-chemokine receptor-2 (CCR2)-and CC-chemokine ligand-2 (CCL2)-dependent IM recruitment. Furthermore, we provide evidence indicating that IM contribute to the severity of the pathology of STm-induced colitis and the generation of hostderived nitrate used by STm for growth in the lumen of the inflamed intestine. Collectively, these findings indicate that IM provide a niche for STm expansion in the lumen of the inflamed intestine.
Results

iNOS-producing IM infiltrate ceca of mice infected with STm
We previously showed that IM (i.e., CD11b + Ly6C hi Ly6G -cells) recruited from bone marrow into tissues of mice persistently infected with STm produce NO by an iNOS-dependent mechanism [20] . To begin to evaluate the role of IM in NTS gastroenteritis, we used the well-established C57BL/6J mouse model of STm-induced colitis [6] . This widely used model is highly relevant because the robust inflammatory response elicited during STm infection closely resembles the pathology of NTS gastroenteritis in humans [7, 8] . The model involves treatment of the mice with a single dose of streptomycin (Sm) prior to STm infection [6] , which lowers colonization resistance and induces dysbiosis of the gut microbiota [13] . Without Sm pretreatment, STm does not induce the robust inflammatory response that resembles the pathology of NTS gastroenteritis in humans [6] . C57BL/6J mice were left untreated or treated with Sm one day prior to inoculation with PBS or STm (suspended in PBS). Transcript analysis revealed that, by day 4 after inoculation, expression of Ccl2, which encodes chemokine (C-C motif) ligand-2 (CCL2), a potent monocyte chemoattractant, had been induced in ceca of mice pretreated with Sm and inoculated with STm, but not in ceca of mice left untreated or treated with Sm or STm alone (Fig 1A) . Consistent with this finding, flow cytometric analysis revealed that IM had accumulated in ceca of mice pretreated with Sm and inoculated with STm, but not in ceca of mice left untreated or treated with Sm or STm alone (Fig 1B and S1A Fig). As expected, similar results were obtained with respect to neutrophilic granulocyte recruitment (S1A and S1B Fig). Furthermore, bacterial burden assays showed that, at the time of harvest, STm were present in the cecal lumen of all mice inoculated with STm, with the number of STm colony forming units (CFU) recovered being greatest in mice treated with Sm (Fig 1C) .
Follow-up experiments revealed that both IM (Fig 1D) and neutrophilic granulocytes (i.e., CD11b + Ly6C int Ly6G + cells) (S1C Fig) accumulated in ceca of infected mice (Fig 1E) over time, and were also found in the cecal lumen (Fig 1F and S1D Fig) . Furthermore, Western blot analysis revealed that IM but not neutrophilic granulocytes purified by FACS from ceca of Sm-pretreated mice inoculated with STm expressed iNOS (Fig 1G) . Thus, iNOS-producing IM infiltrate ceca of mice infected with STm.
Inactivation of T3SS-1 and T3SS-2 renders STm unable to induce Ccr2-and
Ccl2-dependent IM recruitment
STm causes intestinal inflammation by employing two type-three secretion systems, T3SS-1 and T3SS-2, which mediate epithelial cell invasion and intramacrophage survival, respectively [21, 22] . Inactivation of T3SS-1 (through a mutation in invA, which encodes an essential structural component of T3SS-1 [21] ) and T3SS-2 (through a mutation in ssaD, which encodes an essential structural component of T3SS-2 [21] ) renders STm unable to induce intestinal inflammation in the murine model of STm-induced colitis [23] . Interestingly, mutant strains of STm that do not induce colitis or cannot respire nitrate exhibit a reduced ability to compete with other microbes in the lumen of the gut [13] [14] [15] 24] .
To determine if T3SS-1 and T3SS-2 are required for STm to induce IM infiltration of the cecum, mice were treated with Sm prior to intragastric inoculation with PBS, wild-type (WT) STm, or invA, ssaD, or invA ssaD mutant STm. On day 4 after inoculation, IM had accumulated in ceca of mice inoculated with WT STm, but not invA, ssaD, or invA ssaD mutant STm, with accumulation being lowest in mice inoculated with invA ssaD mutant STm (Fig 2A) . Similar results were obtained with respect to neutrophilic granulocyte recruitment ( S2A Fig). As expected, lower numbers of invA, ssaD, and invA ssaD mutant STm (relative to WT STm) were recovered from the cecal lumen of infected mice, with numbers of invA ssaD mutant STm being lowest (Fig 2B) .
CCR2 plays a critical role in the emigration of Ly6C hi monocytes from bone marrow [25] , while CCL2 is a known ligand for CCR2 [26] . To evaluate the roles of CCR2 and CCL2 in STm-induced colitis, WT, Ccr2-deficient (Ccr2 
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-/-mice, with substantial numbers of STm recovered from the cecal lumen (Fig 2C and   2D 
IM contribute to the severity of the pathology of STm-induced colitis
To evaluate the contribution of IM to the pathology of STm-induced colitis, WT and Ccr2
-/-mice were left untreated or treated with Sm prior to intragastric inoculation with PBS or STm. On day 4 after inoculation, ceca were harvested and processed for blinded, semiquantitative histopathological analysis. As expected, the robust inflammatory response elicited in ceca of WT mice treated with Sm and inoculated with STm (relative to WT mice left untreated or WT mice treated with Sm or STm alone) was characterized by dense suppurative-to-pyogranulomatous infiltration of the lamina propria and submucosa (Fig 3A and 3B) . Additional histopathological changes associated with STm infection included erosion and attenuation of the surface epithelium, crypt hyperplasia and abscessation, lymphocytolysis and lymphadenitis of the cecal lymphoid tissue, and accumulation of suppurative exudate in the cecal lumen ( Fig  3A and 3B ). In contrast, the inflammatory response elicited in ceca of Ccr2 -/-mice treated with Sm and inoculated with STm (relative to Ccr2 -/-mice left untreated or Ccr2 -/-mice treated with Sm or STm alone) was significantly less robust (Fig 3A and 3B) . Furthermore, ceca from Ccr2 -/-mice treated with Sm and inoculated with STm displayed an overall inflammation score that was attenuated (relative to ceca from WT mice treated with Sm and inoculated with STm) and indicative of an inflammatory infiltrate characterized as predominantly neutrophilic, with appreciable attenuation of mononuclear cell recruitment (Fig 3B) .
In parallel experiments, transcript analysis revealed that STm-induced expression of Il1b, Tnfa, Ifng, and Il22, which encode the proinflammatory cytokines interleukin-1β, tumor necrosis factor-β, interferon-γ, and interleukin-22, respectively, was diminished in Sm-pretreated Ccr2 -/-mice relative to WT mice (Fig 3C-3F ). In contrast, STm-induced expression of Cxcl1 and Cxcl2, which encode neutrophil chemoattractants chemokine (C-X-C motif) ligand-1 and -2, respectively, was normal in Sm-pretreated Ccr2 -/-mice relative to WT mice (Fig 3G   and 3H ). Collectively, these results indicate that IM contribute to the severity of the pathology of STm-induced colitis.
IM contribute to the STm-induced generation of nitrate in the cecal mucosa
To evaluate the contribution of CCR2 and, therefore, IM to STm-induced Nos2 expression in the cecum, WT and Ccr2 -/-mice were treated with Sm prior to intragastric inoculation with PBS or STm. On day 4 after inoculation, ceca were harvested and total RNA was isolated from cecal tissues. Subsequent transcript analysis revealed that STm-induced Nos2 expression in the cecum was diminished in Ccr2 -/-mice relative to WT mice, but not abolished (Fig 4A) . Similar results were obtained when total protein was isolated from said cecal tissues and subjected to Western blot analysis to measure levels of iNOS (Fig 4B and S3A Fig) .
In parallel experiments, a fluorometric 2,3-diaminonaphtalene (DAN) assay [27] was used to measure nitrate concentrations in cell-free cecal mucus extracts. Analysis of DAN assay results revealed that nitrate concentrations in cecal mucus from Ccr2 -/-mice treated with Sm and inoculated with STm were significantly lower than those in cecal mucus from WT mice treated with Sm and inoculated with STm (Fig 4C) . Analysis of DAN assay results also revealed that, under these conditions, nitrate concentrations in cecal mucus from WT and Ccr2 -/-mice treated with
Sm but left uninfected were comparable (Fig 4C and S3B Fig) . Collectively, these results indicate that IM contribute to the STm-induced generation of nitrate in the cecal mucosa. The observed effects and effect sizes in Ccr2 -/-mice further suggest that there may be cells other than IM that also contribute to the STm-induced generation of nitrate in the cecal mucosa.
IM contribute to the generation of host-derived nitrate used by STm for growth in the lumen of the inflamed intestine
To further evaluate the significance of these findings as they relate to the ability of STm to use host-derived nitrate for growth in the lumen of the inflamed intestine, WT and Ccr2 -/-mice were treated with Sm prior to intragastric inoculation with a 1:1 mixture of differentially marked WT and nitrate respiration-deficient napA mutant STm. Consistent with published results [14] , WT STm had outcompeted napA mutant STm for growth in the cecal lumen of WT mice by day 4 after inoculation (Fig 5A) . In contrast, however, WT STm had failed to outcompete napA mutant STm for growth in the cecal lumen of Ccr2 -/-mice (Fig 5A) . Similar results were obtained when fecal samples were analyzed over time (Fig 5B) . Collectively, these results indicate that IM contribute to the generation of host-derived nitrate used by STm for growth in the lumen of the inflamed intestine.
Discussion
We report that iNOS-producing IM infiltrate ceca of mice infected with STm and that inactivation of T3SS-1 and T3SS-2 renders STm unable to induce Ccr2-and Ccl2-dependent IM recruitment. Furthermore, we report that IM contribute to the severity of the pathology of STm-induced colitis and the generation of host-derived nitrate used by STm for growth in the lumen of the inflamed intestine. Collectively, our findings indicate that IM promote post-antibiotic STm expansion in the lumen of the inflamed intestine, providing new, fundamental insights into how STm exploit gut inflammation to promote disease progression.
We postulate that IM contribute both directly and indirectly to the generation of hostderived nitrate used by STm for growth in the lumen of the inflamed intestine (Fig 6) . IM may contribute directly to the generation of host-derived nitrate used by STm for growth in the lumen of the inflamed intestine by expressing Nos2 (Fig 1G) and indirectly by potentiating Nos2 expression by other cells such as intestinal epithelial cells (IEC) (Fig 6) . Our model is consistent with the notion that IM may not be the sole source of host-derived nitrate and that cells other than IM (e.g., tissue-resident cells) may help promote nitrate-dependent STm expansion in the lumen of the inflamed intestine.
Epithelial Nos2 expression is induced during the course of intestinal inflammation and in response to stimulation with various cytokines (e.g., IFN-γ, IL-22) [28] [29] [30] [31] . Whether epithelial Nos2 expression contributes to post-antibiotic STm expansion in the lumen of the inflamed intestine is not known. However, depletion of butyrate-producing gut microbes by antibiotic treatment reduces epithelial signaling through the intracellular butyrate sensor peroxisome proliferator-activated receptor (PPAR)-γ, resulting in increased epithelial Nos2 expression, luminal nitrate availability, and dysbiotic Enterobacteriaceae expansion [32] . Thus, hostderived nitrate used by STm for growth in the lumen of the inflamed intestine may be generated by both IM and IEC, where the contribution of IM may be direct and indirect, and the contribution of IEC may be mediated by the depletion of butyrate-producing gut microbes and potentiated by proinflammatory cytokines.
Additionally, we postulate that IM contribute both directly and indirectly to the pathology of STm-induced colitis. IM may contribute directly to the pathology of STm-induced colitis by producing proinflammatory cytokines (e.g., TNF-α) and indirectly by licensing other cells (e. g., NK cells, γ:δ T cells, intraepithelial lymphocytes, group 3 innate lymphocytes) to produce proinflammatory cytokines (e.g., TNF-α, IFN-γ, IL-22), some of which, as stated above, can potentiate epithelial Nos2 expression. Thus, IM may play a key role in coordinating induced innate immune responses in the inflamed intestine.
As for our finding that high bacterial burdens persist in the cecal lumen of mice infected with invA ssaD mutant Salmonella (Fig 2B) , it is well established that Salmonella mutants unable to trigger gut inflammation can replicate to near wild-type levels in the non-inflamed intestine. Together with the notion that Salmonella, at least initially, replicates in a noninflamed gut, our finding suggests that Salmonella can leverage multiple metabolic pathways to access diverse and redundant resources, including carbon and respiration substrates, from diverse origins (e.g., dietary products, host-derived products, and resident microbiota byproducts).
In summary, this work establishes that IM play a key role in the pathogenesis of STminduced colitis. The conceptual advances resulting from this work are of broad relevance for understanding both infectious and digestive diseases such as NTS gastroenteritis, ulcerative colitis, and Crohn's disease, all of which are characterized by intestinal inflammation and dysbiosis of the gut microbiota.
Materials and methods
Contact for reagent and resource sharing
Further information and requests for resources and reagents should be directed to and will be fulfilled by the Corresponding Author, Adrianus W.M. van der Velden (a.vandervelden@sto-nybrook.edu).
Ethics statement
Studies that used live mice were performed in accordance with relevant institutional and national guidelines and regulations [33] . All experiments involving mice were approved by the Stony Brook University Institutional Animal Care and Use Committee (protocol number 2012-2075-11.12.21-FAR-Mi) and conform to the relevant regulatory standards. Euthanasia was conducted using carbon dioxide inhalation in accordance with the American Veterinary Medical Association Guidelines for Euthanasia of Animals 
Microbe strains
Studies used various strains of STm. STm strain IR715 [34] , a spontaneous nalidixic acid-resistant derivative of STm strain 14028 (American Type Culture Collection), was used as the WT strain, except for studies involving mixed infections, where STm strain SL1344 [35] was used as the WT strain.
To generate an invA mutant STm strain in the IR715 strain background, bacteriophage P22 HTint-mediated transduction was used to move the invA mutation from an isogenic derivative of STm strain BA715 [36] that was generated when bacteriophage KB1int-mediated transduction was used to move the invA mutation from STm strain SWL2020 [37] . An isogenic derivative of STm strain IR715 lacking ssaD was generated by use of the lambda red recombinase method [38] . Briefly, the kanamycin resistance gene carried by plasmid pCLF4 [39] was amplified by use of PCR, with primers ssaD_mut Fwd and ssaD_mut Rev (S1 Table) . The resulting PCR product was electroporated into STm strain IR715 carrying plasmid pKD46 [38] to ultimately generate, by homologous recombination, a kanamycin-resistant and ampicillin-sensitive ssaD mutant STm strain. This strain was verified by PCR and DNA sequencing after which bacteriophage P22 HTint-mediated transduction was used to move the ssaD mutation into STm strain IR715. To generate an invA ssaD mutant STm strain in the IR715 strain background, bacteriophage P22 HTint-mediated transduction was used to move the ssaD mutation from the ssaD mutant STm strain into the invA mutant STm strain. An isogenic derivative of STm strain SL1344 lacking napA was also generated by use of the lambda red recombinase method, essentially as described above and with primers napA_mut Fwd and napA_mut Rev (S1 Table) .
With the use of standard microbiological techniques, bacteria were grown aerobically overnight at 37˚C in lysogeny broth (3 ml) or on lysogeny agar. When necessary, carbenicillin (100 μg/ml; Teknova Cat#2105; CAS#4800-94-6), chloramphenicol (30 μg/ml; Sigma Cat#0378-25G; CAS#56-75-7), kanamycin (60 μg/ml; TCI America Cat#K0047-25G; CAS#25389-94-0), nalidixic acid (50 μg/ml; Alfa Aesar Cat#J63550-14; CAS#3374-05-8), or streptomycin (100 μg/ml; Fisher Scientific Cat#BP910-50; CAS#3810-74-0) was added to the culture medium to select for various (mutant) STm strains in the IR715 or SL1344 strain backgrounds.
Mouse infections
Naïve mice were left untreated or treated with Sm (0.1 ml of a 200 mg/ml solution in PBS administered orally) one day prior to intragastric inoculation with 0.1 ml of PBS or 1 x 10 8 CFU of STm suspended in PBS. To improve the consistency of the infections, food (but not water) was withheld for 6-8 hours prior to inoculation. Immediately after inoculation, food was provided ad libitum. Tenfold serial dilutions of the inoculum were plated to confirm the inoculum titer. At various times after inoculation (up to day 4), ceca were harvested and processed for downstream analysis, and cecal contents were collected for enumerating STm CFU.
For mixed infections, mice were treated with Sm prior to intragastric inoculation with 1 x 10 8 CFU of a 1:1 mixture of differentially marked WT and napA mutant STm in the SL1344 strain background (to assess the ability of the host to generate nitrate used by STm for growth in the lumen of the gut). WT and napA mutant STm in the SL1344 strain background were used because, unlike STm strain IR715, STm strain SL1344 carries a prophage encoding SopE, a type III effector that boosts nitrate-dependent STm expansion in the lumen of the inflamed intestine by enhancing iNOS expression in the cecal mucosa [18] . Mixed infections provide a sensitive measure of virulence attenuation referred to as the competitive index [40] . Tenfold serial dilutions of the inoculum were plated to confirm the inoculum titer and input ratio. Fecal pellets were collected daily and cecal contents were collected on day 4 after inoculation for enumerating both WT and napA mutant STm CFU. Competitive indices were calculated by dividing the number of napA mutant STm by the number of WT STm and normalized to the input ratio.
RNA isolation and transcript analysis
Ceca were cut open, luminal contents were removed, and tissues were extensively washed with PBS to remove any remaining luminal contents, cut into 0.5 cm 2 pieces, and transferred into Lysing Matrix D, 2 ml Tubes (MP Biomedicals Cat#6913-100) containing 1 ml TRI Reagent (Molecular Research Center Cat#TR 118). Next, tissues were homogenized for 45 sec using a Mini-Beadbeater-16 (BioSpec Products) and centrifuged to remove debris. RNA was isolated according to the TRI Reagent manufacturer's protocol. Briefly, chloroform was added to the TRI Reagent suspensions, which were then mixed and centrifuged. The top aqueous layer containing RNA was removed and transferred to a new tube, after which RNA was precipitated with isopropanol. Next, the precipitated RNA was pelleted and washed with ethanol prior to removal of contaminating genomic DNA with TURBO DNA-free Kit (Invitrogen Cat#AM1907), and cDNA was synthesized from the RNA with Verso cDNA Synthesis Kit (Thermo Fisher Scientific Cat#AB1453B). The resulting samples were used as templates for transcript analysis by quantitative PCR. Using gene-specific primers (S1 Table) and PerfeCTa SYBR Green FastMix (Quantabio Cat#95072-012), transcript analysis was performed on a CFX96 Touch Real-Time PCR Detection System (Biorad).
Flow cytometric analysis
Ceca were cut open, luminal contents were collected, and tissues were extensively washed with PBS to remove any remaining luminal contents. Tissues were then cut into 0. To analyze cells present in the cecal lumen, luminal contents were suspended in 5ml PBS, filtered through a 70 μm nylon filter, and washed twice with PBS prior to being suspended in 7 ml of a 30% Percoll solution (100% = 9 part Percoll and 1 part 10x PBS; GE Healthcare Cat#17-5445-02) that was then overlaid onto 4 ml of an 80% Percoll solution and centrifuged for 40 min at 300 x g, with the brake off, at room temperature. Cells at the interface between the 30% and 80% Percoll solutions were removed with a Pasteur pipette, added to 10 ml of PBS, pelleted and washed twice with PBS, and then suspended in FACS buffer prior to staining, essentially as above (Zombie Violet Fixable Viability Dye (BioLegend Cat#423114) was added to the staining protocol).
Data were acquired on a BD FACScan flow cytometer (BD Biosciences) with Digital Extra Parameter Upgrade (DxP8) and FlowJo Collectors' Edition software (both Cytek), and were analyzed with FlowJo v10 software (www.flowjo.com). Where indicated, cells were sorted on a FACSAria flow cytometer (BD Biosciences) in the Stony Brook University Research Flow Cytometry Core Facility.
Western blot analysis
Ceca were cut open, luminal contents were collected, and tissues were extensively washed with PBS to remove any remaining luminal contents and cut into 0.5 cm 2 pieces. Next, tissues were transferred into Lysing Matrix D, 2 ml Tubes containing 1 ml RIPA buffer supplemented with cOmplete and PhosSTOP (protease and phosphatase inhibitor cocktails, respectively; Roche Cat#11836153001 and Cat#4906837001), and homogenized for 45 sec using a Mini-Beadbeater-16. Sorted cells were pelleted, washed with PBS, and suspended (2 x 10 7 cells/ml) in RIPA buffer supplemented with cOmplete and PhosSTOP. Lysates were centrifuged and supernatants were collected. Bradford assay (Bio-Rad Protein Assay Dye Reagent Concentrate; BioRad Laboratories Cat#5000006) was used to determine the protein concentrations of the samples, which were normalized (based on protein concentration), mixed with Laemmli/SDS sample buffer, incubated for 5 min at 95˚C, subjected to centrifugation to pellet debris, and loaded onto an 8% Tris-Tricine polyacrylamide gels with discontinuous buffering systems [41] . Following gel electrophoresis, proteins were transferred onto polyvinylidene difluoride membranes by use of a Trans-Blot SD Semi-Dry Transfer Cell System (Bio-Rad). Expression of iNOS and β-actin was detected with anti-NOS2 antibody (1:1,000; BioLegend Cat#690902; RRID: AB_2629826) and anti-β-actin antibody (1:1,000; Cell Signaling Technology Cat#4967S; RRID: AB_330288), respectively. For detection, Alexa Fluor Plus 800-conjugated goat anti-rabbit IgG secondary antibody (1:10,000; Invitrogen Cat#A32735; RRID: AB_2633284) and Alexa Fluor 680-conjugated goat anti-mouse IgG secondary antibody (1:10,000; Invitrogen Cat#A21058; RRID: AB_2535724) were used in combination with an Odyssey CLx Imaging System (LI-COR). Specific band intensities were quantified, after which relative levels of iNOS were normalized to β-actin.
Histological analysis
Cecal tips, which contain lymphoid patches, were collected and fixed overnight at 4˚C in 10% formalin (Fisher Scientific Cat#SF100-4), after which the samples were extensively washed in PBS before being routinely embedded in paraffin, sectioned (5 μm section per sample), and stained with hematoxylin and eosin in the Stony Brook University Research Histology Core Facility. A board-certified veterinary anatomic pathologist performed blinded, semi-quantitative histopathological analysis of the cecal sections.
Nitrate measurements
Ceca were harvested, luminal contents were removed, and cecal mucus layers were collected by way of gentle scraping, using the backside of surgical scissors. Cecal mucus was collected in microcentrifuge tubes containing 0.5 ml of sample buffer (Nitric Oxide Assay Kit, Millipore Sigma Cat#482655), after which samples were homogenized by vortexing, centrifuged (10,000 x g) for 20 min at 4˚C, and filtered using a 10K MWCO centrifugal filter with PES membrane (VWR Cat#82031-348). Levels of nitrate were quantitated using the fluorometric 2,3-diaminonaphtalene (DAN) assay-based Nitric Oxide Assay Kit.
Quantification and statistical analysis
The significance of the results described in this study was determined by use of a number of different statistical analyses performed with Prism 6 (GraphPad Software; www.graphpad. com). All of the statistical details of the experiments can be found in the figure legends. P values of less than 0.05 were considered to be statistically significant. Asterisks indicate statistically significant differences for designated post hoc test comparisons ( ���� , P < 0.0001; ��� , P < 0.001; �� , P < 0.05; � , P < 0.05, n.s., not significant). 
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